The oncogenic role of RAD21 in NSCLC is mediated by NIPBL via H3K27 demethylation and suggest its use as a potential novel diagnostic marker and therapeutic target for NSCLC. The gene discussed is NIPBL; the disease is non-small cell lung carcinoma.